Volanesorsen is an antisense inhibitor of APOC3 and is believed to increase insulin sensitivity by 57%; furthermore, it reduces fructosamine, glycated hemoglobin, and glycated albumin levels and can be used to treat T2DM [58]. This evidence concerns the gene APOC3 and type 2 diabetes mellitus.